Table:
begin	end	state
1	5	non-cytoplasmic
6	26	transmembrane
27	40	cytoplasmic
41	62	transmembrane
63	65	non-cytoplasmic
66	93	transmembrane
94	126	cytoplasmic
127	150	transmembrane
151	161	non-cytoplasmic
162	184	transmembrane
185	191	cytoplasmic
192	210	transmembrane
211	229	non-cytoplasmic
230	250	transmembrane
251	274	cytoplasmic
275	297	transmembrane
298	324	non-cytoplasmic
325	349	transmembrane
350	370	cytoplasmic
371	391	transmembrane
392	401	non-cytoplasmic
402	422	transmembrane
423	428	cytoplasmic
429	447	transmembrane
448	453	non-cytoplasmic
454	474	transmembrane
475	494	cytoplasmic

Input:
>GFF3017 FitnessBrowser__psRCH2:GFF3017
MNVSTPTLITFVIYIAAMILIGFIAYRATKNFSDYILGGRSLGSFVTALSAGASDMSGWL
LMGLPGAIFVAGLSESWIAIGLIVGAWLNWLFVAGRLRVHTEHNHNALTLPDYFSHRFED
ESRMLRIFSALVILVFFTIYCASGVVAGARLFESTFGMPYEYALWVGAAATILYVFIGGF
LAVSWTDTVQATLMIFALLVTPVFVILALGDMGTAMATIEAQNPANFDMFRGLSFVAIVS
LLAWGLGYFGQPHILVRFMAADSIKTIPNARRIGMTWMILTLAGAVAVGFLGIAYFADHP
EQAGAVSQNGERVFMELVKILFNPWVAGIILSGVLAAVMSTLSAQLLVSSSALTQDFYKA
MLRKNASQTELVWVGRGMVLLIALIAIGIASNPDSKVLGLVSYAWAGFGAAFGPVVLISL
LWKRMTRNGALVGMLVGAVTVVVWKEFIGLGLYEIIPGFILASIAIFVVSKLGAEPAPSI
VKRFEEADADYHAG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server